The Impact of De‐escalation of Antianginal Medications on Health Status After Percutaneous Coronary Intervention

BACKGROUND: Antianginal medications (AAMs) can be perceived to be less important after percutaneous coronary intervention (PCI) and may be de‐escalated after revascularization. We examined the frequency of AAM de‐escalation at discharge post‐PCI and its association with follow‐up health status. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Qintar, Mohammed, Towheed, Arooge, Tang, Fengming, Salisbury, Adam C., Ho, P. Michael, Grantham, J. Aaron, Spertus, John A., Arnold, Suzanne V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721850/
https://www.ncbi.nlm.nih.gov/pubmed/29054844
http://dx.doi.org/10.1161/JAHA.117.006405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721850/
https://www.ncbi.nlm.nih.gov/pubmed/29054844
http://dx.doi.org/10.1161/JAHA.117.006405

Ejemplares similares